Jun Ni

2.0k total citations
58 papers, 1.6k citations indexed

About

Jun Ni is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Jun Ni has authored 58 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 8 papers in Cardiology and Cardiovascular Medicine and 8 papers in Oncology. Recurrent topics in Jun Ni's work include Heme Oxygenase-1 and Carbon Monoxide (7 papers), Renin-Angiotensin System Studies (5 papers) and Histone Deacetylase Inhibitors Research (3 papers). Jun Ni is often cited by papers focused on Heme Oxygenase-1 and Carbon Monoxide (7 papers), Renin-Angiotensin System Studies (5 papers) and Histone Deacetylase Inhibitors Research (3 papers). Jun Ni collaborates with scholars based in China, Hong Kong and United States. Jun Ni's co-authors include Li Zhang, Hong Xue, Yü Huang, Li Zhou, Limin Lü, Roland Stocker, Robyn G. Midwinter, Hafizah Abdul Hamid, Louise Dunn and Christopher R. Parish and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Circulation Research.

In The Last Decade

Jun Ni

55 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jun Ni China 22 680 254 210 190 180 58 1.6k
Meiping Guan China 25 751 1.1× 241 0.9× 258 1.2× 116 0.6× 266 1.5× 56 1.6k
Amrutesh S. Puranik United States 18 862 1.3× 278 1.1× 146 0.7× 234 1.2× 216 1.2× 33 1.9k
Ting C. Zhao United States 23 806 1.2× 313 1.2× 213 1.0× 82 0.4× 161 0.9× 46 1.5k
Guijun Qin China 24 553 0.8× 212 0.8× 208 1.0× 108 0.6× 220 1.2× 88 1.7k
Jun Hao China 23 629 0.9× 167 0.7× 264 1.3× 174 0.9× 146 0.8× 57 1.3k
Brian B. Ratliff United States 23 794 1.2× 259 1.0× 465 2.2× 218 1.1× 240 1.3× 43 2.0k
Zongji Zheng China 25 781 1.1× 270 1.1× 324 1.5× 123 0.6× 189 1.1× 42 1.5k
Xu Teng China 26 563 0.8× 272 1.1× 202 1.0× 192 1.0× 246 1.4× 88 1.9k
Matilde Alique Spain 26 846 1.2× 183 0.7× 278 1.3× 353 1.9× 200 1.1× 64 1.8k

Countries citing papers authored by Jun Ni

Since Specialization
Citations

This map shows the geographic impact of Jun Ni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Ni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Ni more than expected).

Fields of papers citing papers by Jun Ni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Ni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Ni. The network helps show where Jun Ni may publish in the future.

Co-authorship network of co-authors of Jun Ni

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Ni. A scholar is included among the top collaborators of Jun Ni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Ni. Jun Ni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peng, Lan, et al.. (2025). Beyond the heart: a review exploring non-cardiovascular effects of vasoactive agents. Frontiers in Pharmacology. 16. 1533437–1533437.
2.
Ni, Jun, et al.. (2024). Abstract No. 569 Yttrium-90 (Y90) Radioembolization as a Safe and Effective Treatment Option for Hepatic Uveal Melanoma Metastases. Journal of Vascular and Interventional Radiology. 35(3). S209–S210.
3.
Li, Zhengqiang, Jun Ni, Xinyu Zhu, et al.. (2024). Antioxidant and anti-inflammatory function of Eupatorium adenophora Spreng leaves (EASL) on human intestinal Caco-2 cells treated with tert-butyl hydroperoxide. Scientific Reports. 14(1). 10509–10509. 2 indexed citations
5.
Jia, Wei‐Guo, et al.. (2023). Efficacy and safety of methylene blue injection for intractable idiopathic pruritus ani: a single-arm metaanalysis and systematic review. Techniques in Coloproctology. 27(10). 813–825. 2 indexed citations
6.
He, Fei, Nan Cai, Jun Ni, et al.. (2022). The HMGB1-RAGE axis induces apoptosis in acute respiratory distress syndrome through PERK/eIF2α/ATF4-mediated endoplasmic reticulum stress. Inflammation Research. 71(10-11). 1245–1260. 13 indexed citations
7.
Zhang, Nannan, et al.. (2022). Research hotspots and frontiers about role of visual perception in stroke: A bibliometric study. Frontiers in Neurology. 13. 958875–958875. 4 indexed citations
8.
Huang, Xian, Zhenyan Jiang, Jun Tu, et al.. (2021). SIRT3-mediated deacetylation of NLRC4 promotes inflammasome activation. Theranostics. 11(8). 3981–3995. 54 indexed citations
9.
Liang, Xiaohong, et al.. (2021). Systematic Pan-Cancer Population-Based Analysis Reveals the Incidence and Prognosis of Lung Metastases at Diagnosis. Journal of Oncology. 2021. 1–8. 4 indexed citations
10.
Shi, Yingfeng, Jun Ni, Lunxian Tang, et al.. (2021). Requirement of Histone Deacetylase 6 for Interleukin-6 Induced Epithelial-Mesenchymal Transition, Proliferation, and Migration of Peritoneal Mesothelial Cells. Frontiers in Pharmacology. 12. 722638–722638. 21 indexed citations
11.
Ni, Jun, et al.. (2020). IgA nephropathy associated with thalassemia: a case report. BMC Nephrology. 21(1). 182–182. 1 indexed citations
13.
Ni, Jun, Liuqing Xu, Xiaoqing Zheng, et al.. (2019). 3-deazaneplanocin A protects against cisplatin-induced renal tubular cell apoptosis and acute kidney injury by restoration of E-cadherin expression. Cell Death and Disease. 10(5). 355–355. 49 indexed citations
14.
Wang, Fangfang, Jun Ni, Lei Wu, et al.. (2019). Gender disparity in the survival of patients with primary myelodysplastic syndrome. Journal of Cancer. 10(5). 1325–1332. 16 indexed citations
15.
Lv, Lin, Patrick Ming‐Kuen Tang, Yong You, et al.. (2016). The pattern recognition receptor, Mincle, is essential for maintaining the M1 macrophage phenotype in acute renal inflammation. Kidney International. 91(3). 587–602. 132 indexed citations
16.
Ni, Jun, Yang Shen, Zhen Wang, et al.. (2014). P300-dependent STAT3 acetylation is necessary for angiotensin II-induced pro-fibrotic responses in renal tubular epithelial cells. Acta Pharmacologica Sinica. 35(9). 1157–1166. 38 indexed citations
17.
Dunn, Louise, Robyn G. Midwinter, Jun Ni, et al.. (2013). New Insights into Intracellular Locations and Functions of Heme Oxygenase-1. Antioxidants and Redox Signaling. 20(11). 1723–1742. 133 indexed citations
18.
Xue, Hong, Ping Yuan, Jun Ni, et al.. (2013). H2S Inhibits Hyperglycemia-Induced Intrarenal Renin-Angiotensin System Activation via Attenuation of Reactive Oxygen Species Generation. PLoS ONE. 8(9). e74366–e74366. 66 indexed citations
19.
Xue, Hong, Ping Yuan, Zhen Wang, et al.. (2012). Counteraction between angiotensin II and angiotensin-(1–7) via activating angiotensin type I and Mas receptor on rat renal mesangial cells. Regulatory Peptides. 177(1-3). 12–20. 32 indexed citations
20.
Ni, Jun, et al.. (2006). Study on Myelopathy Associated with Systemic Lupus Erythematosus in 6 Cases. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026